Related Experiment Video
Updated: May 20, 2026
Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
Published on: June 13, 2015
Choosing and using Drosophila models to characterize modifiers of Huntington's disease
Edward W Green1, Flaviano Giorgini
1Department of Genetics, University of Leicester, Leicester, UK.
Insights
Huntington's disease (HD) research utilizes Drosophila models to study neurodegenerative defects caused by mutant huntingtin protein. These models offer sensitive behavioral readouts for early disease detection and therapeutic screening.
Area of Science:
- Neuroscience
- Genetics
- Model Organism Research
Background:
- Huntington's disease (HD) is a fatal inherited neurodegenerative disorder.
- It results from a polyglutamine (polyQ) expansion in the huntingtin protein (htt).
- Mutant htt expression causes cellular defects observed in HD patients.
Purpose of the Study:
- To review recently developed Drosophila models of HD.
- To provide guidance on experimental approaches for screening these models.
- To identify modifiers of mutant htt-mediated toxicity.
Main Methods:
- Utilizing Drosophila melanogaster as a model organism for HD research.
- Leveraging Drosophila's complex nervous system for sensitive behavioral analysis.
- Employing established molecular toolkits for genetic manipulation and screening.
Main Results:
- Drosophila models recapitulate key cellular and behavioral defects of HD.
- Behavioral assays in Drosophila provide sensitive readouts of neuronal disruption.
- These models facilitate the identification of genetic modifiers of toxicity.
Conclusions:
- Drosophila models are valuable tools for studying HD pathogenesis.
- Behavioral screening in Drosophila offers insights into early disease stages.
- This approach aids in the discovery of potential therapeutic targets for HD.
Abstract:
HD (Huntington's disease) is a fatal inherited gain-of-function disorder caused by a polyQ (polyglutamine) expansion in the htt (huntingtin protein). Expression of mutant htt in model organisms is sufficient to recapitulate many of the cellular defects found in HD patients. Many groups have independently developed Drosophila models of HD, taking advantage of its rapid life cycle, carefully annotated genome and well-established molecular toolkits. Furthermore, unlike simpler models, Drosophila have a complex nervous system, displaying a range of carefully co-ordinated behaviours which offer an exquisitely sensitive readout of neuronal disruption. Measuring HD-associated changes in behaviour in Drosophila therefore offers a window into the earliest stages of HD, when therapeutic interventions might be particularly effective. The present review describes a number of recently developed Drosophila models of HD and offers practical guidance on the advantages and disadvantages of various experimental approaches that can be used to screen these models for modifiers of mutant htt-mediated toxicity.
